BAUSCH + LOMB CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.7 CAD | -0.18% |
|
+4.58% | -4.28% |
| Jul. 10 | Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target | MT |
| Jul. 08 | RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 179B | ||||||
| 98.84B | ||||||
| 65.34B | ||||||
| 45.41B | ||||||
| 44.94B |
